GeneDx Holdings (WGS) Current Leases (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Current Leases of $3.4 million for Q4 2021, down 2.48% year-over-year from $3.5 million in Q4 2020, and down 2.48% quarter-over-quarter from $3.5 million in Q4 2020.

GeneDx Holdings (WGS) Current Leases (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has reported Current Leases for 2 consecutive years, with $3.4 million the latest figure, recorded in Q4 2021.

  • In Q4 2021, Current Leases fell 2.48% year-over-year to $3.4 million; the TTM figure through Dec 2021 stood at $3.4 million (down 2.48% YoY), while the FY2021 annual figure was $3.4 million, down 2.48% from the prior year.
  • Current Leases slipped to $3.4 million in Q4 2021 per WGS's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $3.5 million in Q4 2020 and bottomed at $3.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn 180.00 Mn
10 GeneDx Holdings 2.08 Bn 1.94 Bn 78.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 3.42 Mn
Dec 31, 2020 3.51 Mn